Stacey M Stein

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Metastatic Colorectal Cancer

High Resolution

Gene Expression

Cross Sectional

Top Venues

Cancer research communications

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey S Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M Stein, Jeremy Kortmansky, Kimberly L Johung, Ranjit S Bindra, Patricia M LoRusso, Kurt A Schalper
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer research communications 3 (6) (2023)
Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey S Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M Stein, Jeremy Kortmansky, Kimberly L Johung, Ranjit S Bindra, Patricia M LoRusso, Kurt A Schalper
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer research communications 3 (6) (2023)
Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey S Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M Stein, Jeremy Kortmansky, Kimberly L Johung, Ranjit S Bindra, Patricia M LoRusso, Kurt A Schalper
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer research communications 3 (6) (2023)
Stacey M Stein, Jeremy Snider, Siraj M Ali, Rebecca A Miksad, Brian M Alexander, Emily H Castellanos, Alexa B Schrock, Russell W Madison, Akshay Swaminathan, Jeffrey M Venstrom, Margaret McCusker
Real-world association of HER2/ERBB2 concordance with trastuzumab clinical benefit in advanced esophagogastric cancer. Future oncology (London, England) 17 (31) (2021)